The Medical News

The Medical News

Reviewed by Kate Anderton, B.Sc. (Editor) Jan 7 2020 With more people with diabetes and pre-diabetes looking for strategies to help control blood sugar, new research from UBC's Okanagan campus suggests that ketone monoester drinks--a popular new food supplement--may help do exactly that. There has been a lot of excitement and interest in ketone drinks and supplements, which have really only been on the market and available to consumers for the last couple of years. Because they're so new, there's very little research on how they can influence metabolism and we're among the first to look at their use in non-athletes. Jonathan Little, associate professor at UBC Okanagan's School of Health and Exercise Sciences and study lead author Little says that Type 2 diabetes is a disease whereby the body is unable to control the level of sugar in the blood because defects in the functioning of a hormone called insulin. "It's a disease that's becoming alarmingly common in Canada and approaching what many would consider epidemic levels," he says. "While Type 2 diabetes can be controlled with medications or injectable insulin, many people are looking to options that don't require taking pills every day or that are less invasive." Ketone supplements are proving fertile ground for research into Type 2 diabetes because, according to Little, ketones are the natural fuel source of the body when it's in ketosis--the metabolic byproduct of consuming a low carbohydrate, ketogenic diet. "There is mounting evidence that a low carbohydrate ketogenic diet is very effective in controlling blood sugar and even reversing Type 2 diabetes," says Little. "We wanted to know what would happen if artificial ketones were given to those with obesity and at risk for Type 2 diabetes but who haven't been dieting." Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More